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ABSTRACT
Patients with the nucleotide excision repair (NER) disorder xeroderma
pigmentosum (XP) are highly predisposed to develop sunlight-induced
skin cancer, in remarkable contrast to photosensitive NER-deficient tri-
chothiodystrophy (TTD) patients carrying mutations in the same XPD
gene. XPD encodes a helicase subunit of the dually functional DNA
repair/basal transcription complex TFIIH. The pleiotropic disease pheno-
type is hypothesized to be, in part, derived from a repair defect causing
UV sensitivity and, in part, from a subtle, viable basal transcription
deficiency accounting for the cutaneous, developmental, and the typical
brittle hair features of TTD. To understand the relationship between
deficient NER and tumor susceptibility, we used a mouse model for TTD
that mimics an XPD point mutation of a TTD patient in the mouse
germline. Like the fibroblasts from the patient, mouse cells exhibit a
partial NER defect, evident from the reduced UV-induced DNA repair
synthesis (residual repair capacity ;25%), limited recovery of RNA syn-
thesis after UV exposure, and a relatively mild hypersensitivity to cell
killing by UV or 7,12-dimethylbenz[a]anthracene. In accordance with the
cellular studies, TTD mice exhibit a modestly increased sensitivity to
UV-induced inflammation and hyperplasia of the skin. In striking contrast
to the human syndrome, TTD mice manifest a clear susceptibility to UV-
and 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis, albeit
not as pronounced as the totally NER-deficient XPA mice. These findings
open up the possibility that TTD is associated with a so far unnoticed
cancer predisposition and support the notion that a NER deficiency
enhances cancer susceptibility. These findings have important implica-
tions for the etiology of the human disorder and for the impact of NER on
carcinogenesis.
INTRODUCTION
Genomic instability is an eminent feature in the progression of a
normal somatic cell into a transformed cancer cell. To preserve DNA
integrity, a network of genome “caretaking” mechanisms has evolved,
including DNA repair processes. The NER3 system eliminates a wide
diversity of DNA lesions, such as cyclobutane pyrimidine dimers and
(6-4) photoproducts (main DNA damage induced by UV light), in-
trastrand cross-links, bulky chemical adducts, and some forms of
oxidative damage (1), in a complex multistep “cut-and-paste” type of
reaction (1, 2). The importance of NER is illustrated by three rare,
autosomal recessive photosensitive human NER-deficiency syn-
dromes: XP, CS, and TTD (3).
XP patients, with a defect in one of the NER components (XPA-
XPG), are very sensitive to sunlight and have a ;1000-fold increased
risk of developing skin cancer. The age of onset of nonmelanoma skin
tumors is reduced from 60 years to 8 years of age (4). Additionally,
pigmentation abnormalities in sunlight-exposed areas are a hallmark,
and, frequently, accelerated neurodegeneration occurs (reviewed in
Ref. 3).
CS is characterized by photosensitivity and several additional
symptoms that are difficult to rationalize via a defect in NER, such as
severe growth retardation (referred to as cachectic dwarfism), neuro-
dysmyelination, and skeletal abnormalities. A mutation in the CSA or
CSB gene is associated with a selective defect in transcription-coupled
repair. This NER subpathway accomplishes very efficient removal of
lesions that block transcription and that are less efficiently repaired by
the complementary NER process, GGR (5). Remarkably, CS patients
seem not cancer-prone. Moreover, patients with combined features of
XP and CS were identified with defects in the XPB, XPD, or XPG
genes (6–8). Adding to the clinical complexity, XPB and XPD are
also involved in the photosensitive form of the third NER syndrome,
TTD (9, 10).
TTD shares many features with CS, including (neuro)developmen-
tal and skeletal abnormalities. In addition, TTD patients display
ichthyosis (scaling of the skin) and striking brittle hairs and nails (11),
the hallmark of the disease. TTD patients have a reduced life expect-
ancy, but extensive clinical heterogeneity exists, ranging from mild
growth retardation to life-threatening cachexia. Like CS, TTD seems
to be not associated with skin cancer predisposition. Moreover, con-
siderable heterogeneity in severity of the NER defect is seen (12, 13),
but no clear correlation exists with the severeness of many TTD
features. In fact, a subgroup of nonphotosensitive, NER-proficient
TTD patients is also known, suggesting that the NER impairment and
the typical TTD phenotypes are clinically, and perhaps molecularly,
unrelated. In support of this idea, it was discovered that XPB and XPD
are essential DNA helicase subunits of the dually functional DNA
repair/basal transcription initiation factor TFIIH (14–18). Previously,
we proposed that mutations in those genes may not only affect NER,
causing XP and the photosensitivity in CS and TTD, but, depending
on the mutation, may also subtly impair basal transcription explaining
the typical CS and TTD features (19, 20). Consistent with this hy-
pothesis, mutation analysis of XPD in different patients indicated that
each causative mutation is syndrome-specific (21–25). Mostly subtle
point mutations are found, consistent with the essential role of XPD in
basal transcription initiation. Moreover, by gene targeting, we showed
that a XPD null allele is lethal in mice (26).
To study the complex clinical symptoms and the paradoxical ab-
sence of skin cancer in NER-deficient TTD patients, we generated a
mouse model for TTD by mimicking the XPDR722W allele in the
mouse germline as found in five TTD patients (27). TTD mice reflect,
to a remarkable extent, the pleiotropic features of the human disorder,
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including growth delay, reduced fertility and life span, cutaneous
abnormalities, and UV sensitivity of cultured fibroblasts. Like in
patients, TTD mice displayed the remarkable brittle hair phenotype
due to a reduction of hair-specific cysteine-rich matrix proteins.
Having established a valid mouse model for TTD, this study presents
further characterization of the repair defect of TTD mice and exam-
ines the crucial issue of cancer predisposition.
MATERIALS AND METHODS
NER-deficient Mice and Cell Lines. The term TTD mouse is used for
mice homozygous for the XPDR722W allele (27). Similarly, XPA, CSB, and
XPC refer to mice homozygous for the targeted allele in the respective genes
(28–30). Because no heterozygous effect was observed in any experiment,
both heterozygous mutant and homozygous wild-type mice are referred to as
wild-type. Mice used for generation of MEFs and determination of UV-
induced hyperplasia were in mixed 129-C57Bl/6 background. Mice in the
MED assay were mixed 129-C57Bl/6 (XPC and TTD) and pure C57Bl/6 (XPA
and CSB). No effect of genetic background on MED in wild-type mice was
noted.4
Human TTD fibroblast cell lines TTD7PV and TTD12PV, TTD1VI, and
TTD1BEL were kindly provided by Drs. M. Stefanini (Istituto di Genetica
Biochimica ed Evoluzionistica CNR, Pavia, Italy), A. Sarasin (Laboratory of
Molecular Genetics, CNRS, Vuilejuij, France), A. R. Lehmann (MRC Cell
Mutation Unit, Sussex University, Falmer, Brighton, United Kingdom),
respectively.
DNA Repair Characteristics of MEFs. MEFs for all genotypes were
obtained in our laboratory, as described before (27).
For UDS testing MEFs were seeded onto coverslips. The next day, cells
were washed with PBS and irradiated at 16 J/m2 UV-C (TUV lamp; Philips).
Subsequently, cells were incubated for 2.5 h in culture medium containing 10
mCi/ml [3H]-thymidine, fixed, and subjected to autoradiography as described
before (31).
RNA synthesis recovery was measured according to the protocol of Mayne
and Lehmann (32). In short, coverslip-grown cells were exposed to 10 J/m2 of
254-nm UV light, labeled with [3H]-uridine, and processed for autoradiogra-
phy. The relative rate of RNA synthesis was expressed as the ratio of grains
over UV-exposed to unexposed nuclei. In general, UDS values are very well
comparable within an experiment, but show variation between experiments.
For UV survival assays, cell cultures were exposed to UV and allowed to
grow for another 4–5 days before reaching confluency. Cells were labeled with
[3H]-thymidine, as described above, rinsed with PBS, and lysed. The number
of proliferating cells in each dish was estimated by scintillation counting of
radioactivity during a 3-h pulse-labeling. Cell survival was expressed as the
ratio of irradiated over unirradiated cells.
Quantitation of UV-induced Inflammation. To determine the MED,
mice were exposed to broadband UVB radiation from a filtered (Schott-
WG305 filter) Hanovia Kromayer Lamp Model 10S (Slough, United King-
dom). This is a hand-held lamp that allows short exposures to limited skin
areas (such as the ears) by placing the circular port (approximately 2 cm2) in
close contact to the skin (33). The dose rate was 150 J/m2/s (280–400 nm), and
each strain of mice was examined at least at five different doses in triplicate.
Besides macroscopic evaluation of edema and erythema reactions, the
increase in skin thickness was determined as a value for acute UVB effects. Ear
skin was exposed to the Kromayer Lamp because ears do not contain a fur
(shaving was not necessary). Ear thickness was measured before and 24 h after
UVB exposure using an engineer’s micrometer (Mitutoyo model 193-10;
Veenendaal, the Netherlands). The lowest dose that was able to induce a
significant swelling response (i.e., edema reaction) was denoted to be the MED
for that strain of mice.
UV- and DMBA-induced Skin Effects and Carcinogenesis. Acute ef-
fects in the skin of shaven wild-type CSB and TTD mice were assessed by
exposure to 100 J/m2/day UV-B light (250–400 nm; American Philips F40 sun
lamps) during 4 consecutive days. Skin samples were obtained from two mice
per genotype, 24 h after the last exposure and were routinely processed (H&E
staining) for histopathology.
UV-induced carcinogenesis was studied by chronically exposing the shaven
back of 8 TTD and 13 wild-type mice (starting age, 8 weeks) to UVB light
using an incremental-dose protocol starting at 80 J/m2/day and gradually
increasing to 670 J/m2/day (250–400 nm). Timer-controlled American Philips
F40 sunlamps were positioned 33 cm above the cage and yielded a dose rate
of 13.3 J/m2/min (250–400 nm). Chemically induced carcinogenesis in the
mouse skin was tested with DMBA in the complete carcinogenesis protocol
(30). Shaven TTD mice and wild-type litter mates (15 per genotype, 8–12
weeks of age) received 20 weekly applications of 10 mg of DMBA dissolved
in 100 ml of acetone.
Mice were checked for tumor appearance once a week. Skin tumors were
routinely processed for histopathological examination.
RESULTS
Repair Characteristics and Genotoxic Sensitivity of NER-defi-
cient Cells. We first systematically compared various DNA repair
parameters in primary MEFs established from wild-type mice, XPA
mice with a complete NER deficiency (30), XPC mice carrying a
selective defect in GGR (29), CSB mice with a specific TCR defect
(28), and TTD mice (27). The UV-induced UDS level is considered a
parameter mainly for GGR activity because TCR-defective CSB cells
have UDS levels in the wild-type range (Table 1), whereas GGR-
deficient XPC MEFs display ;30% residual repair synthesis. TTD
MEFs exhibit only ;20–40% UDS similar to cells of the correspond-
ing patients. A significant proportion of this is derived from TCR
because inactivating this NER subpathway in CSB/TTD double mu-
tant MEFs reduces residual UDS to less than half (data not shown).
TCR activity was assessed indirectly by analysis of the cellular
capacity to perform RNA synthesis 16 h after UV irradiation (32). As
expected, persistence of lesions in transcriptionally active DNA re-
duces RNA synthesis in TCR-deficient XPA and CSB MEFs (Table
1), whereas XPC MEFs exhibit a response in the wild-type range. In
TTD MEFs, RNA synthesis recovery is only ;20% of wild type,
comparable with what we found in TTD1VI cells (data not shown).
This indicates that a small but significant level of residual TCR is
present in TTD. Thus, both GGR and TCR are clearly affected in TTD
MEFs, but substantial residual repair activity for both subpathways
persists.4 J. Garssen, unpublished data.
Table 1 DNA repair characteristics of NER-deficient mice and MEFs
Strain UDS (%)a
RNA synthesis
recovery (%) D10 (J/m2)b MED (J/m2) Hyperplasiac Cancer-pronec
Wild type 100 100 8 1500 2 NAd
XPA ,5 ,5 0.9 150 11 11
CSB .95 ,5 1.3 150 11 1
XPC 30 .95 1.4 1500 1e 11
TTD 25 ;20 4.9 1200 1/2 1
a The UDS values represent the mean of several independent experiments. For proper comparison, the data of all cell lines in the text are from one experiment.
b UV dose at 10% survival, deduced from Fig. 1.
c Epidermal hyperplasia and cancer development after genotoxic treatment. Data are complied (Refs. 28, 29, and 30 and this study). The relative severeness of the symptoms are
indicated as far as differences in experimental setup between the studies allow.
d NA, not applicable.
e Data complied from the study by Sands et al. (29) and our unpublished results.
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To study the toxic consequences of defective repair, UV survival of
TTD MEFs was compared with that of XPA, XPC, CSB, and wild-
type MEFs (Fig. 1). The relative sensitivities of the different cell lines
(XPA . CSB . XPC . TTD . wt) correlates very well with
literature on the corresponding NER-deficient human cells (1, 3) and
our own unpublished data. It is worth noting that the sensitivity of
TTD MEFs to UV-induced cell killing is very mild (see Fig. 1 and
Table 1). The modest hypersensitivity of TTD MEFs was confirmed
using DMBA (a compound that induces bulky DNA adducts that are
also substrates for NER; data not shown). To confirm that the
XPDR722W allele is associated with mild genotoxic sensitivity, both in
mouse and man, we performed UV survival experiments with four
human TTD fibroblast lines harboring the XPDR722W allele. Under the
conditions used, UV sensitivity was in the same order as for TTD
MEFs, again very mild when compared with XPA cells (data not
shown).
In Vivo Sensitivity of NER-deficient Mice. UV irradiation has
two very distinct effects on the skin. First, acute UV-induced inflam-
mation occurs, macroscopically characterized by erythema (redness)
and edema (swelling) of the skin. This effect is predominantly caused
by lesions in actively transcribed DNA (34) and, thus, serves as a
parameter for TCR. Long-term exposure causes scaling of the skin,
histologically characterized by hyperkeratosis and hyperplasia of the
epidermis, which is due to persistence of lesions in transcribed genes,
as well as the genome overall. Though photosensitivity is reported in
TTD patients, the severity of either symptom is not known. TTD mice
allowed us to characterize these parameters in vivo. UV-induced
inflammation is expressed as the minimal UV dose required to induce
edema (MED). As shown in Table 1, the TCR defect of XPA and CSB
mice is associated with low MED and TCR proficiency in XPC mice
with a response in the wild-type range. TTD mice have a slightly
reduced MED compared with wild-type and XPC mice (1200 J/m2
versus 1500 J/m2), but not nearly as outspoken as XPA and CSB mice
(150 J/m2), consistent with the idea that TCR is only partially affected
in TTD mice.
Susceptibility to UV-induced hyperplasia of TTD mouse epidermis
was examined by irradiating the shaven backs of wild-type, TTD, and
CSB mice on 4 consecutive days with 100 J/m2 UVB. As depicted in
Fig. 2, epidermis of irradiated CSB mice displayed hyperplasia as
reported before (28), whereas both wild-type and TTD mice were not
detectably affected at this low UV dose. Similarly, only mild hyper-
plasia and inflammation was noted on histological sections of TTD
skin, but not wild-type skin after six treatments with 10 mg of DMBA
(data not shown).
In conclusion, comparison with NER-deficient mice demonstrates
that TTD mice are mildly sensitive to genotoxic agents in vivo.
UV Light Induced Skin Cancer Susceptibility. It was of special
interest to investigate cancer predisposition under experimental con-
ditions in the TTD mouse model in view of the notion that TTD
patients, despite their NER deficiency, do not seem to be cancer-
prone. To this end, 8 TTD mice and 13 wild-type mice were chron-
ically exposed on the shaven back to low daily doses of UV light. As
the experiment continued, it became apparent that the TTD mice
failed to develop clear cutaneous scaling and eye lesions as registered
in XPA and CSB mice, despite the fact that the cumulative UV dose
for the TTD mice was much higher than that used in the XPA and
CSB experiments (103 kJ/m2 versus 25 and 50 kJ/m2, respectively
(28, 30) After 18 weeks, TTD mice started to develop multiple tumors
Fig. 1. Comparison of genotoxic sensitivity of various NER-deficient cells. UV
survival of primary MEFs of NER-deficient mice is indicated. For proper comparison, all
survivals were performed in one experiment. For each genotype, identical results were
obtained with several other lines (data not shown). UV sensitivity has been described
before for all cells used (27–30). Bars, the SE of the mean, omitted when smaller than the
symbol.
Fig. 2. UV-induced hyperplasia in CSB mice, but
not in wild-type and TTD mice. Skin sections of TTD,
wild-type, and CSB mice are indicated, untreated or
treated with UVB (100 J/m2/day) for 4 consecutive
days on the shaven back. Skin samples were taken 24 h
after the final irradiation. Note the thick cornified layer
in TTD skin (arrow) and hyperplasia in UV-irradiated
CSB skin (arrow). The difference in thickness between
treated and untreated TTD skin lies within the normal
range observed.
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in UV-exposed areas (Fig. 3, A and B), which were histopathologi-
cally identified as SCCs. From week 27 onward, tumors appeared in
wild-type mice. The significantly reduced latency time of developing
tumors (P , 0.01) together with the overt increased tumor yield
demonstrate that TTD mice are more susceptible to UV carcinogen-
esis than wild-type mice.
DMBA-induced Skin Cancer Susceptibility. To confirm the can-
cer proneness of TTD mice, we subjected 15 wild-type and 15 TTD
mice to a complete DMBA carcinogenesis protocol, by weekly ap-
plying 10 mg of DMBA to the shaven back for a period of 20 weeks.
After 12 weeks TTD mice started to develop skin tumors, whereas the
first tumor in wild-type mice was only observed after 21 weeks (see
Fig. 4, A and B). Despite the very weak cytotoxic effect of DMBA
application to the skin, the clear decrease in latency time and the
dramatic increase in tumor yield demonstrate that TTD mice are prone
to chemical-induced skin cancer.
Tumors on the skin of TTD mice were histopathologically identi-
fied as SCCs (Fig. 4C) and papillomas (Fig. 4D) at a ratio of 2:3
(Table 2), and one tumor was classified as a fibrosarcoma. In contrast,
wild-type mice developed predominantly SCCs, whereas, using a
similar protocol, XPA-deficient mice only developed papillomas (Ref.
30 and this study).
DISCUSSION
Since the identification of CS and TTD as DNA repair disorders,
the paradoxical absence of skin cancer predisposition in these
NER-deficient patients has been puzzling. The set of NER-defi-
cient mice generated in our and collaborating laboratories allows a
quantitative and in vivo approach toward elucidating the role of
DNA damage and repair in the multistep process of carcinogenesis.
This study describes cellular repair parameters, quantitation of
UV-induced inflammation of the skin, and carcinogenic properties
of TTD mice compared with other NER-deficient mouse mutants.
In contrast to the human syndrome, TTD mice are clearly predis-
posed to develop skin cancer, although not as cancer-prone as XPA
mice.
Repair Defect in TTD Mice. The TTD-specific XPDR722W al-
lele, which we mimicked in the mouse genome, is associated with
a clear, but partial, DNA repair defect in human fibroblasts. RNA
synthesis recovery was severely, but not completely, abolished
(Table 1). Moreover UDS, UV-induced mutagenicity levels in a
plasmid-based study (35) and UV survival using a protocol with
noncycling cells were comparable between TTD/XPDR722W fibro-
blasts and fibroblasts from XP patients of complementation group
D (12, 25).
Despite the repair defect, TTD mouse skin appears not very sensi-
tive to either UV-induced inflammation (only slightly more sensitive
than wild-type mice) or hyperplasia induced by UV or DMBA. In
TTD patients, photosensitivity of the skin has been reported, but
ethics constrain experimental quantitation of this symptom. In addi-
tion, mild pigmentation abnormalities on sunlight exposure, one of the
hallmark features of XP, have been reported sporadically in TTD
patients (25, 36), suggesting that the TTD repair defect resembles XP
in this respect, albeit to a mild extent. In vivo photosensitivity in TTD
mice and patients may be moderated by UV shielding by the thick
hyperkeratotic epidermis. However, also the eyes of TTD mice, which
Fig. 3. UV induced skin tumor development in wild-type and TTD mice. Shaven mice
were subjected to an UVB carcinogenesis protocol (see “Materials and Methods”). ,
wild-type mice; E, TTD mice. A and B, incidence, latency, and yield of skin tumor
formation after UV treatment. The cumulative dose is 103 kJ/m2 (250–400 nm).
Fig. 4. DMBA induced skin tumor development in wild-type and TTD mice. Shaven
mice were subjected to a DMBA carcinogenesis protocol (see “Materials and Methods”).
, wild-type mice, E, TTD mice. A and B, incidence, latency, and yield of skin tumor
formation after DMBA treatment. Histopathological examination of DMBA-induced skin
tumors in TTD mice shows mixture of SCCs (C) and papillomas (D).
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are histologically normal,5 fail to display the extreme UV-induced
lesions of chronically exposed XPA mice (37). Instead, the mild
genotoxic sensitivity in TTD seems to be established at the cellular
level for several reasons. First, under the experimental conditions used
here, the TTD MEFs and the fibroblasts of four TTD patients carrying
the same XPDR722W allele display a comparable mild UV sensitivity.
Mild UV sensitivity seems to be a more common feature among TTD
fibroblasts, although some heterogeneity is apparent.6 Second, the
mutational spectrum in TTD cells, considered as a fingerprint of the
repair defect, resembles more of wild-type than of XP-D cells (35,
38), and TTD cells are less sensitive to UV-induced transcription
inhibition of the ICAM-1 marker gene than XP-D cells (39). A
possible rationale for the milder consequences of the TTD repair
defect was provided by Eveno et al. (40), who showed that photo-
sensitive TTD cells have defective CPD repair but (partially) profi-
cient repair of 6-4PPs. This was confirmed by Marionnet et al. (41),
who demonstrated that CPDs are the predominant mutagenic lesions
in TTD cells. Lesion-dependent efficiency of repair may, thus, under-
lie the mild sensitivity of NER-deficient TTD cells, but this has not
been analyzed in the TTD mouse yet.
TTD Syndrome and Cancer Proneness. An important and in-
triguing enigma associated with TTD is the observation that repair-
deficient TTD patients seem to be free of cancer despite their NER
defect, which is in striking contrast to XP and XP/CS cases from the
same XP-D complementation group (3). Previously, differences in
catalase activity (42), natural killer cell activity (43), and apoptotic
response (44) have been reported between TTD and XP-D patients,
but the relative importance of each of these parameters has not yet
been studied in detail. Obviously, they may be addressed in vivo in the
TTD mouse mutant. The most significant observation reported here is
that TTD mice exhibit enhanced UV- and chemical-induced cancer
susceptibility. This shows that TTD does not somehow intrinsically
protect against skin cancer and is in agreement with the dogma that a
defect in NER predisposes to cancer, but is in apparent contrast with
clinical data. Notably, as much as the experimental setup allowed,
TTD mice seemed less cancer-prone than XPA mice. The reduction in
latency of UV-induced tumors was less pronounced in TTD mice
compared with XPA mice (30), and the tumor type induced by DMBA
was intermediate: XPA and wild-type mice develop predominantly
papillomas and SCCs, respectively, whereas TTD mice develop a
mixture of both tumor types. We propose that the molecular charac-
teristics of the TTD repair defect, reflected by low UV sensitivity,
imposes less severe predisposition to UV-induced skin cancer in TTD
and patients than in XP. Furthermore, possible and established phys-
iological differences between mouse and man (e.g., in metabolic rate,
immune system, apoptotic response, spontaneous and induced muta-
tion rates, and certain repair parameters) may influence the difference
in cancer proneness differently in the two species. However, addi-
tional factors may also explain the paradoxical absence of skin cancer
development in TTD patients.
XP and TTD are clinically very different syndromes of which a
defect in basal transcription is thought to participate in the clinical
outcome of TTD. Discussion of the difference in cancer predisposition
between XP and TTD should include possible consequences of repair-
and transcription-related phenotypes on tumor development. For in-
stance, the thick cornified layer of TTD patients will shield the
underlying proliferating keratinocytes of the basal layer significantly
from UV irradiation and, thus, reduce the mutagenic dose. Further-
more, TTD keratinocytes, the target cells for skin tumorigenesis, have
a defect in late stages of terminal differentiation (27) that might have
an impact on transformation to a tumor cell. At least as relevant is the
severity of the disease and the young age at which many TTD patients
die, which probably does not allow time to accumulate enough dam-
age to develop skin tumors, as suggested previously for CS (28). This
is certainly likely for the five patients with the R722W mutation
because they were all severely affected and died very young (at least
four before age 5; Ref. 25). In conclusion, the experimental mouse
model reveals that TTD syndrome in man may be associated with
hitherto unnoticed cancer proneness, although the residual repair
activity of TTD cells protects largely against the cytotoxicity and
carcinogenicity of UV. This may be particularly relevant under nor-
mal conditions when the low damage load does not exceed the limited
DNA repair capacity of the TTD cells.
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